Ended FY2025 with $102.9 million in cash and a debt-free balance sheet.
Progressed NRC, manufacturing and supply chain milestones supporting the Company's planned 2028 commercialization timeline.
NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. ("Terra Innovatum" or the "Company") (NASDAQ: NKLR), a developer of micro-modular nuclear reactors, today reported its fourth quarter and fiscal year 2025 financial and operating results and announced the filing of its Annual Report on Form 10‑K for the fiscal year ended December 31, 2025.
4Q & FY 2025 Summary
Filed the Company's Annual Report on Form 10‑K for fiscal year 2025, completing its first annual reporting cycle as a public company and establishing internal reporting precedents as a cross‑border issuer.
Ended the year with $102.9 million in cash and cash equivalents, including proceeds from the business combination with GSR III Acquisition Corp. and related equity financing on October 9, 2025, providing sufficient capital to fund the Company's expected licensing, manufacturing and FOAK deployment activities.
Advanced NRC licensing with submission of key documents and topical reports, and remain on track to submit the Safety Analysis Report by mid‑2026, supporting the Company's planned path to NRC approval and initial commercial operations.
Progressed supply chain readiness and early manufacturing activities with ATB Riva Calzoni and other partners to support planned FOAK deployment and broader commercial scale-up.
Continued to build a robust commercial pipeline, including non‑binding MOUs totaling 100 SOLO units across data centers, industrial facilities and government‑related opportunities.
Selected Rock City Admiral Parkway in Illinois as the FOAK deployment site, with an option for up to 50 commercial SOLO units and commercialization potential starting in 2028.
Alessandro Petruzzi, Co‑Founder & CEO of Terra Innovatum, said, "Terra Innovatum and the broader nuclear industry are at a critical inflection point where massive clean energy demand, regulatory momentum and geopolitical tailwinds are converging. As the first public microreactor developer to rely on non‑proliferant, commercially available low‑enriched uranium fuel and off‑the‑shelf components, we believe we are uniquely positioned to capture this opportunity and become a major player in the new era of nuclear energy production by delivering safe, reliable and low‑cost power to the world."
Petruzzi continued, "Our financial and operational progress in 2025 has reinforced that conviction. Our design is complete, we believe our licensing path with the U.S. NRC is well defined, our supply chain is fully in place, and we have the funds expected to be necessary to reach FOAK deployment. In 2026, our primary focus will be to: 1) progress the U.S. NRC process with the submittal of the Safety Analysis Report by mid‑2026, 2) continue ramping manufacturing activities at third‑party supplier facilities, and 3) convert our robust pipeline and MOUs into a growing book of committed SOLO orders. We are confident in our ability to execute on these priorities and excited about the opportunities ahead."
Katherine Williams, Chief Financial Officer of Terra Innovatum, added, "On behalf of the Board and management team, I want to thank our shareholders and the broader market for their patience as we completed a comprehensive review of our earnings cycle and filed our first Annual Report on Form 10‑K as a public company. With the work we have completed to date, the Board is confident that Terra Innovatum is positioned to pair disciplined, transparent reporting with the operational execution needed to deliver on its FOAK and long‑term growth objectives, and to meet the market's expectations for timely, high-quality disclosure."
"Taken together with the filing of our 2025 Form 10-K, we view these results as reinforcing Terra Innovatum's capacity to execute on SOLO without the need for incremental near‑term capital," continued Williams. "The company exits 2025 with sufficient cash to be fully funded through expected FOAK licensing and construction, and to support continued execution of the broader SOLO program and its key regulatory and commercialization milestones, ...
